David O. Watson

Companies

• Apellis Pharmaceuticals, Inc.General counsel Nov 8, 2017 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• APApellis Pharmaceuticals, Inc.0 shares²May 14, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• May 14, 2026Returned to company 7,363 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 6,001 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 11,874 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 55,986 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 32,072 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 55,986 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 55,986 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 27,993 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 27,993 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 28,508 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 28,508 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Returned to company 41,250 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026Granted 41,250 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 50,136 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 10,000 shares of Apellis Pharmaceuticals, Inc.²
• May 14, 2026U 144,517 shares of Apellis Pharmaceuticals, Inc.²
• Jan 28, 2026Granted 55,986 shares of Apellis Pharmaceuticals, Inc.³
• Jan 22, 2026Sold 7,832 shares at $21.77 of Apellis Pharmaceuticals, Inc.⁴
• Jan 20, 2026Sold 2,475 shares at $19.79 of Apellis Pharmaceuticals, Inc.⁵
• Jan 13, 2026Sold 5,780 shares at $22.19 of Apellis Pharmaceuticals, Inc.⁶
• Jan 7, 2026Exercised options 888 shares at $14.95 of Apellis Pharmaceuticals, Inc.⁷
• Dec 16, 2025Sold 5,000 shares at $24.49 of Apellis Pharmaceuticals, Inc.⁸
• Nov 17, 2025Sold 5,000 shares at $20.06 of Apellis Pharmaceuticals, Inc.⁹
• Oct 16, 2025Sold 5,000 shares at $25.22 of Apellis Pharmaceuticals, Inc.¹⁰
• Sep 16, 2025Sold 5,000 shares at $24.34 of Apellis Pharmaceuticals, Inc.¹¹